228 related articles for article (PubMed ID: 32438681)
1. Spectrum of Germline
Santonocito C; Rizza R; Paris I; Marchis L; Paolillo C; Tiberi G; Scambia G; Capoluongo E
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32438681
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Spectrum of Germline
Fanale D; Fiorino A; Incorvaia L; Dimino A; Filorizzo C; Bono M; Cancelliere D; Calò V; Brando C; Corsini LR; Sciacchitano R; Magrin L; Pivetti A; Pedone E; Madonia G; Cucinella A; Badalamenti G; Russo A; Bazan V
Front Oncol; 2021; 11():682445. PubMed ID: 34178674
[TBL] [Abstract][Full Text] [Related]
3. Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.
Santonocito C; Scapaticci M; Guarino D; Bartolini A; Minucci A; Concolino P; Scambia G; Paris I; Capoluongo E
Breast; 2017 Dec; 36():74-78. PubMed ID: 29020660
[TBL] [Abstract][Full Text] [Related]
4. Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in
Incorvaia L; Fanale D; Badalamenti G; Bono M; Calò V; Cancelliere D; Castiglia M; Fiorino A; Pivetti A; Barraco N; Cutaia S; Russo A; Bazan V
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380732
[TBL] [Abstract][Full Text] [Related]
5. Beyond
Germani A; Petrucci S; De Marchis L; Libi F; Savio C; Amanti C; Bonifacino A; Campanella B; Capalbo C; Lombardi A; Maggi S; Mattei M; Osti MF; Pellegrini P; Speranza A; Stanzani G; Vitale V; Pizzuti A; Torrisi MR; Piane M
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32957588
[TBL] [Abstract][Full Text] [Related]
6.
Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
[TBL] [Abstract][Full Text] [Related]
7. Mutational Analysis of
Stella S; Vitale SR; Martorana F; Massimino M; Pavone G; Lanzafame K; Bianca S; Barone C; Gorgone C; Fichera M; Manzella L
Cancer Manag Res; 2022; 14():1341-1352. PubMed ID: 35411189
[TBL] [Abstract][Full Text] [Related]
8. Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).
Ruiz de Sabando A; Urrutia Lafuente E; García-Amigot F; Alonso Sánchez A; Morales Garofalo L; Moreno S; Ardanaz E; Ramos-Arroyo MA
BMC Cancer; 2019 Nov; 19(1):1145. PubMed ID: 31771539
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer.
Hirasawa A; Imoto I; Naruto T; Akahane T; Yamagami W; Nomura H; Masuda K; Susumu N; Tsuda H; Aoki D
Oncotarget; 2017 Dec; 8(68):112258-112267. PubMed ID: 29348823
[TBL] [Abstract][Full Text] [Related]
10. About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants.
Gutiérrez-Enríquez S; Bonache S; de Garibay GR; Osorio A; Santamariña M; Ramón y Cajal T; Esteban-Cardeñosa E; Tenés A; Yanowsky K; Barroso A; Montalban G; Blanco A; Cornet M; Gadea N; Infante M; Caldés T; Díaz-Rubio E; Balmaña J; Lasa A; Vega A; Benítez J; de la Hoya M; Diez O
Int J Cancer; 2014 May; 134(9):2088-97. PubMed ID: 24130102
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
[TBL] [Abstract][Full Text] [Related]
12. Germline Missense Variants in
Golubeva VA; Nepomuceno TC; Monteiro ANA
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31013702
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.
Capalbo C; Ricevuto E; Vestri A; Ristori E; Sidoni T; Buffone O; Adamo B; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
Ann Oncol; 2006 Jun; 17 Suppl 7():vii34-40. PubMed ID: 16760289
[TBL] [Abstract][Full Text] [Related]
14. Tumor Testing for Somatic and Germline
Peixoto A; Pinto P; Guerra J; Pinheiro M; Santos C; Pinto C; Santos R; Escudeiro C; Bartosch C; Canário R; Barbosa A; Gouveia A; Petiz A; Abreu MH; Sousa S; Pereira D; Silva J; Teixeira MR
Front Oncol; 2020; 10():1318. PubMed ID: 32850417
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.
Maistro S; Teixeira N; Encinas G; Katayama ML; Niewiadonski VD; Cabral LG; Ribeiro RM; Gaburo Junior N; de Gouvêa AC; Carraro DM; Sabino EC; Diz MD; Chammas R; de Bock GH; Folgueira MA
BMC Cancer; 2016 Dec; 16(1):934. PubMed ID: 27914478
[TBL] [Abstract][Full Text] [Related]
16.
Incorvaia L; Fanale D; Bono M; Calò V; Fiorino A; Brando C; Corsini LR; Cutaia S; Cancelliere D; Pivetti A; Filorizzo C; La Mantia M; Barraco N; Cusenza S; Badalamenti G; Russo A; Bazan V
Ther Adv Med Oncol; 2020; 12():1758835920975326. PubMed ID: 33403015
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.
Delgado L; Fernández G; Grotiuz G; Cataldi S; González A; Lluveras N; Heguaburu M; Fresco R; Lens D; Sabini G; Muse IM
Breast Cancer Res Treat; 2011 Jul; 128(1):211-8. PubMed ID: 21190077
[TBL] [Abstract][Full Text] [Related]
18. Age-specific breast and ovarian cancer risks associated with germline
Ho WK; Hassan NT; Yoon SY; Yang X; Lim JMC; Binte Ishak ND; Ho PJ; Wijaya EA; Ng PP; Luccarini C; Allen J; Tai MC; Chiang J; Zhang Z; See MH; Thong MK; Woo YL; Dunning AM; Hartman M; Yip CH; Mohd Taib NA; Easton DF; Li J; Ngeow J; Antoniou AC; Teo SH
Lancet Reg Health West Pac; 2024 Mar; 44():101017. PubMed ID: 38333895
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing.
Patruno M; De Summa S; Resta N; Caputo M; Costanzo S; Digennaro M; Pilato B; Bagnulo R; Pantaleo A; Simone C; Natalicchio MI; De Matteis E; Tarantino P; Tommasi S; Paradiso A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572941
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan.
Muhammad N; Azeem A; Arif S; Naeemi H; Masood I; Hassan U; Ijaz B; Hanif F; Syed AA; Yusuf MA; Rashid MU
Hered Cancer Clin Pract; 2023 Nov; 21(1):22. PubMed ID: 37951914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
